ISO 9001:2015 Certified Company
Several Emerging trends are shaping the Pharmacovigilance and Regulatory Affairs domains in 2025 making their collaboration even more critical: 1. Integration of Artificial Intelligence (AI) and Machine Learning (ML) AI and ML are revolutionizing both PV and RA processes. AI-driven […]
IntroductionThe U.S. Food and Drug Administration (FDA) has recently approved a ground-breaking gene therapy for the treatment of Aromatic L-amino Acid Decarboxylase (AADC) deficiency, marking a significant advancement in the field of genetic disorders. This approval is a beacon of […]
Hyderabad, the capital of Telangana, has emerged as a prominent pharma hub in India, attracting global pharmaceutical companies and investors. Its strategic location, coupled with a favourable business environment, has made it a preferred destination for pharmaceutical manufacturing, research, and […]
New ZLG Document on Transport Verification Published At the end of August, the German Central Authority of the Länder for Health Protection with regard to Medicinal Products and Medical Devices (Zentralstelle der Länder für Gesundheitsschutz bei Arzneimitteln und Medizinprodukten, ZLG) […]
Welcome to the latest edition of our Pharma News and Regulatory News Updates, where we bring you the most significant developments and breakthroughs in the pharmaceutical industry and the latest updates from regulatory agencies worldwide. These highlights from July 1st, […]
Vigilare Biopharma Pvt. Ltd.
Plot no 52,57,1st Floor,
Opp:Prerana Hospital
Balajinagar, Kukatpally,
Hyderabad Telangana,
India -500072
Mail us: info@vigilarebp.com
Novel Techpark,Ground floor, #46, Hosur Rd, Krishna Reddy Industrial Area, Hosapalaya, Bengaluru – 560068.
Mail us: info@vigilarebp.com
NEW JERSEY, USA
14 Breckenridge LN
Monroe NJ 08831
United States
Mail us: info@vigilarebp.com